Anatomical and Functional Outcome of PSG Vs BMG for Urethral Substitution in Long Segment Anterior Urethral Strictures

Sponsor
Al-Azhar University (Other)
Overall Status
Recruiting
CT.gov ID
NCT06056856
Collaborator
(none)
60
1
2
26
2.3

Study Details

Study Description

Brief Summary

This study aims to compare the penile skin graft and buccal mucosal graft for substitution of long anterior urethral strictures using one-sided dorsal perineal approach.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Penile skin graft substituttion urethroplasty
  • Procedure: Buccal Mucosal Graft substitution urethroplasty
N/A

Detailed Description

Since previous studies were:
  • Retrospective and very few were prospective randomized studies

  • Some studies were done on lichen sclerosis cases that have an adverse effect on the PSG outcome.

  • The follow-up duration was longer for PSG patients.

  • Stricture length was usually longer for PSG cases.

This study aims to compare the PSG and BMG for substitution of long anterior urethral strictures using one-sided dorsal perineal approach.

The investigators hypothesize that:

❶ Conducting a well-designed prospective, randomized study can help identify which technique is better than the other.

❷ Using the one-side dorsal approach can improve the outcomes of both techniques and identify their advantages and disadvantages.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
60 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Two-arm parallel assignment. The first arm will be operated using penile skin grafts, The second arm will be operated using buccal mucosal grafts.Two-arm parallel assignment. The first arm will be operated using penile skin grafts, The second arm will be operated using buccal mucosal grafts.
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Anatomical and Functional Outcome of Penile Skin Graft Versus Buccal Mucosal Graft for Urethral Substitution in Long Segment Anterior Urethral Strictures
Actual Study Start Date :
Jun 1, 2022
Anticipated Primary Completion Date :
Jun 1, 2024
Anticipated Study Completion Date :
Aug 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: PSG group

The group of patients who will undergo penile skin graft substitituion of long anterior urethral stricture

Procedure: Penile skin graft substituttion urethroplasty
substitution of long anterior urethral strictures using one-sided dorsal perineal approach

Active Comparator: BMG group

The group of patients who will undergo buccal mucosal graft substitituion of long anterior urethral stricture

Procedure: Buccal Mucosal Graft substitution urethroplasty
substitution of long anterior urethral strictures using one-sided dorsal perineal approach

Outcome Measures

Primary Outcome Measures

  1. The degree of urethral lumen patency. [through study completion, an average of 1 year.]

    Patent urethra as evidenced by uroflowmetry and retrograde urethrography +/- urethroscopy

Secondary Outcome Measures

  1. Lower urinary tract symptoms improvement [6 months]

    lower urinary tract symptoms as assessed by the international prostate symptom score, ranging from 0 to 35, where scores from 0-7 are mild, from 8-19 are moderate, from 20-35 are severe symptoms.

  2. Erectile function assessment [6 months]

    sexual function as assessed by the international index of erectile function-5 questionnaire, ranging from 5-25, where 22-25 is normal, 17-21 is mild ED, 12-16 is mild to moderate ED, 8-11 is moderate ED, and 5-7 is severe ED.

Eligibility Criteria

Criteria

Ages Eligible for Study:
5 Years and Older
Sexes Eligible for Study:
Male
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • The study will include patients with long segment anterior urethral stricture (>2 cm).
Exclusion Criteria:
  • Urethro-cutaneous fistula, urethral abscess or diverticulum.

  • A scarred and unsalvageable urethral plate or scarred perineum.

  • Lichen sclerosis (Balanitis xerotica obliterans).

  • Unhealthy/unavailable buccal mucosa.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Al-Azhar urology department, Al-Azhar university hospitals Cairo Egypt 11511

Sponsors and Collaborators

  • Al-Azhar University

Investigators

  • Study Director: Ahmed Fahim, professor, Urology department, Al-Azhar university, Cairo, Egypt
  • Study Chair: Mostafa Ezzeldein, professor, Urology department, Al-Azhar university, Cairo, Egypt

Study Documents (Full-Text)

More Information

Publications

None provided.
Responsible Party:
Mohamed Ahmed Anwar, Assistant lecturer, Al-Azhar University
ClinicalTrials.gov Identifier:
NCT06056856
Other Study ID Numbers:
  • 773
First Posted:
Sep 28, 2023
Last Update Posted:
Sep 28, 2023
Last Verified:
Sep 1, 2023
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Mohamed Ahmed Anwar, Assistant lecturer, Al-Azhar University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Sep 28, 2023